| Literature DB >> 35029685 |
Chun Zhang1,2, Qin Yu2, Heping Han2, Chaojie Yu1, Alex Nyporko3, Xingshan Tian1, Hugh Beckie2, Stephen Powles2.
Abstract
Glufosinate is an important and widely used non-selective herbicide active on a wide range of plant species. Evolution of resistance to glufosinate in weedy plant species (including the global weed Eleusine indica) is underway. Here, we established the molecular basis of target site glufosinate resistance in Eleusine indica. Full-length E. indica glutamine synthetase (GS) iso-genes (EiGS1-1, 1-2, 1-3, and EiGS2) were cloned, and expression of EiGS1-1 and EiGS1-2 was higher than that of EiGS2. A novel point mutation resulting in a Ser59Gly substitution in EiGS1-1 was identified in glufosinate-resistant plants. Rice calli and seedlings transformed with the mutant EiGS1-1 gene were resistant to glufosinate. Purified mutant EiGS1-1 expressed in yeast was more tolerant to glufosinate than the wild-type variant. These transgenic results correlate with a more glufosinate-resistant GS in the crude tissue extract of resistant versus susceptible E. indica plants. Structural modelling of the mutant EiGS1-1 revealed that Ser59 is not directly involved in glufosinate binding but is in contact with some important binding residues (e.g. Glu297) and especially with Asp56 that forms an intratoroidal contact interface. Importantly, the same Ser59Gly mutation was also found in geographically isolated glufosinate-resistant populations from Malaysia and China, suggesting parallel evolution of this resistance mutation.Entities:
Keywords: zzm321990 Eleusine indicazzm321990 ; glufosinate; glutamine synthetase; target site mutation
Mesh:
Substances:
Year: 2022 PMID: 35029685 PMCID: PMC8982429 DOI: 10.1093/jxb/erac008
Source DB: PubMed Journal: J Exp Bot ISSN: 0022-0957 Impact factor: 6.992
Presence and absence of the Ser59Gly mutation in surveyed field populations from South China
| Population | Location | Resistance status | No. of plants analysed | No. of plants with genotype of EiGS1-1 | |
|---|---|---|---|---|---|
| Ser59 (WT) | Gly59 (mutant) | ||||
| S1 | Fallow field, Guangzhou, China (22°8ʹN, 113°44ʹE) | S | 15 | 15 | |
| P1 | Baiyun, Guangzhou, China (23°35ʹN, 113°39ʹE) | R | 18 | 6 | 12 |
| P2 | Panyu, Guangzhou, China (22°8ʹN, 113°44ʹE) | r | 15 | 14 | 1 |
| P3 | Huadu, Guangzhou, China (23°48ʹN, 113°36ʹE) | r | 18 | 17 | 1 |
| P4 | Sanshui, Foshan, China (23°48ʹN, 112°9ʹE) | r | 15 | 14 | 1 |
| P5 | Yangcun, Huizhou, China (23°48ʹN, 114°46ʹE) | r | 12 | 12 | |
| P6 | Jianggao, Guangzhou, China (23°33ʹN, 113°23ʹE) | S | 9 | 9 | |
| P7 | Xiangang, Zhaoqing, China (23°04ʹN, 112°64ʹE) | S | 10 | 10 | |
| P8 | Boluo, Huizhou, China (23°52ʹN, 114°56ʹE) | S | 15 | 15 | |
| P9 | Maoming, China (21°68ʹN, 110°88ʹE) | S | 8 | 8 | |
| P10 | Mazhang, Zhanjiang, China (21°27ʹN, 110°3ʹE) | S | 6 | 6 | |
| P11 | Qigong, Yangshan, China (24°32ʹN, 112°63ʹE) | S | 11 | 11 | |
| P12 | Jiutan, zengcheng, China (23°11ʹN, 113°58ʹE) | S | 17 | 17 | |
| P13 | Cenxi, Guangxi, China (23°03ʹN, 111°03ʹE) | S | 13 | 13 | |
| P14 | Yulin, Guangxi, China (22°43ʹN, 110°07ʹE) | S | 8 | 8 | |
| P15 | Sanya, Hainan, China (23°42ʹN, 109°28ʹE) | S | 14 | 14 | |
| P16 | Lingshui, Hainan, China (18°51ʹN, 110°04ʹE) | S | 16 | 16 | |
| P17 | Wenchang, Hainan, China (19°61ʹN, 110°72ʹE) | S | 11 | 11 | |
| P18 | Qionghai, Hainan, China (19°25ʹN, 110°47ʹE) | S | 13 | 13 | |
R, r, and S refer to populations that had >50%, 1–10%, and 0% plant survivors, respectively, when treated with glufosinate at the rate (990 g ha−1) that fully controls the susceptible (S1) population. The r populations have zero to low frequency of the mutation, suggesting non-target site resistance mechanisms.
Primers used for glutamine synthetase (GS) gene cloning and expression analysis in Eleusine indica
| Primers | Sequence (5ʹ–3ʹ) |
|---|---|
|
| |
| EiGS1-1-F | ATGGCCTCCCTCACCGACCTC |
| EiGS1-1-R | CACCACTAAATAGATGGACGAG |
| EiGS1-2-F | TGCTTTGGCTTGTGAGATATGG |
| EiGS1-2-R | TGCACAGATCGTCACTCCGGC |
| EiGS1-3-F | TGCGACGCACAATTCACTCGC |
| EiGS1-3-R | GCTCGCACAAACGCATACCC |
| EiGS2-F | AGGATGTGGGGCGCCAGGAG |
| EiGS2-R | AATCACAAGTTCCAGACCGACA |
|
| |
| qGS1-1-F | AGTCATTCGGGCGTGACATT |
| qGS1-1-R | AATGTAGCGAGCAACCCACA |
| qGS1-2-F | GCCGACATCAACACCTTC |
| qGS1-2-R | GGTAATCAGTTTCCCTTCCA |
| qGS1-3-F | AGCCCAGCCACTCCAATG |
| qGS1-3-R | GCGAAGTCCCAATAATACAAA |
| qGS2-F | GGTGTGGTGCTTACCCTTGA |
| qGS2-R | TTCACGCATGGTCTTTGTGC |
| eIF-4-F (reference gene) | CCTACCAAAACGACCACTACGAC |
| eIF-4-R (reference gene) | ATCACCACCGACCTCCTTGCTC |
|
| |
| pOX-GS1-F | TGTTACTTCTGCAGGGTACCATGGCCTCCCTCACCGACCTC |
| pOX-GS1-R | CGGATCCATAACGCGTTCAAGGCTTCCAGATGATGGTGGTC |
| Hyg-F | GACCTGCCTGAAACCGAACTG |
| Hyg-R | CCCAAGCTGCATCATCGAAA |
|
| |
| TansGS1-F | AGAACGGCAAGGGCTACTTC |
| TansGS1-R | CCAGATGATGGTGGTCTCGG |
| SPS-F | TTGCGCCTGAACGGATAT |
| SPS-R | CGGTTGATCTTTTCGGGATG |
|
| |
| Forward primer | CGTAGAATTCATGCACCATCACCATCACCATGCCTCCCTCACC |
| Reverse primer | TGTCTAAGGCGAATTAATTCGCGGCCGCTCAAGGCTTCCAG |
Fig. 1.Partial sequence alignment of glutamine synthetase (GS1) genes of E. indica and other organisms near the Gly47Asp (EiGS1-3) and Ser59Gly (EiGS1-1) mutation sites (arrowed). Aegilops (Aegilops tauschii, LOC109764334), Brachypodi (Brachypodium distachyon, LOC100837122), Dichanthelium (Dichanthelium oligosanthes, OEL18127.1), Oryza (Oryza sativa, XP_015626102.1), Panicum (Panicum miliaceum, RLN07659.1), Saccharum (Saccharum officinarum, AAW21273.1), Setaria (Setaria italica, XP_0049538422), Sorghum (Sorghum bicolor, XP_021313946.1), Zea (Zea mays, NP_001105296.1), Homo (Homo sapiens, S70290.1), Gallus (Gallus gallus, M29076.1), Rattus (Rattus norvegicus, M91652.1), Escherichi (Escherichia coli, BAE77439.1), Fusarium (Fusarium oxysporum, KNB02176.1), Samba (Samba virus, AMK61947.1).
Fig. 2.RT–qPCR analyses of EiGS iso-gene expression in leaf tissue of glufosinate-susceptible (S) and -resistant (R) E. indica (at the five-leaf stage). (A) Basal EiGS expression levels and (B) levels 24 h after glufosinate treatment (495 g ha−1). Data are means ±SE of three replicate samples each containing leaf material of five individual plants (∗ indicates significant difference according to the t-test, P<0.05).
Fig. 3.Expression of the EiGS1-1-R59 gene confers resistance to glufosinate in transgenic rice calli (A), T1 (B, five lines), and T2 (C) seedlings, relative to rice calli/seedings expressing the EiGS1-1-WT gene. Images were taken 3 weeks after treatment.
Fig. 4.Glufosinate dose response of transgenic rice T2 seedlings expressing a single copy of EiGS1-1-R59 versus EiGS1-1-WT. Plants were treated at the three- to four-leaf stage, and survival rate was determined 3 weeks after treatment. Data are means ±SE of pooled results of three WT and three R59 lines.
Parameter estimates for logistic analysis of glufosinate dose required to cause 50% inhibition of plant mortality (LD50) for T2 transgenic rice lines expressing the wild-type (WT) and mutant (R59) EiGS1-1 gene
| Line |
|
|
| LD50 (g ha–1) |
| I50 ratio (mutant/WT) |
|---|---|---|---|---|---|---|
| EiGS1-1-WT | −4.62 ± 3.3 | 101 ± 2.2 | −3.66 ± 0.41 | 742 ± 32 |
| / |
| EiGS1-1-R59 | −10.86 ± 1.5 | 100 ± 0.43 | −4.6 ± 0.41 | 1859 ± 16 |
| 2.5 |
The LD50 values estimated for WT and R59 lines are significantly different according to the t-test, P<0.0001.
Fig. 5.Glutamine synthetase (GS) activity of (A) purified yeast recombinant wild-type (WT) and mutant (R59) EiGS1-1 proteins and (B) in leaf extracts of glufosinate-susceptible (EiGS-S) and -resistant (EiGS-R) E. indica plants. Data are means ±SE of three biological replicates per treatment for EiGS-S and EiGS-R samples, and three technical replicates for yeast recombinant EiGS1-1 samples (∗ indicates significant difference according to the t-test, P<0.05).
Fig. 6.Glufosinate in vitro inhibition of glutamine synthetase (GS) activity of (A) purified yeast recombinant EiGS1-1-WT and EiGS1-1-R59 proteins and (B) in leaf extracts of glufosinate-susceptible (EiGS-S) and -resistant (EiGS-R) E. indica. Data are means ±SE of three biological replicates per treatment for EiGS-S and EiGS-R samples, and three technical replicates for yeast recombinant EiGS1-1 samples.
Parameter estimates for logistic analysis of glufosinate dose required to cause 50% inhibition of GS activity in susceptible (S) and resistant (R) E. indica and in purified yeast recombinant wild-type (WT) and mutant (R59) EiGS1-1 protein.
| Sample |
|
|
| I50 (mM) |
| I50 ratio (R59/WT, R/S) | |
|---|---|---|---|---|---|---|---|
| Yeast recombinant protein | EiGS1-1-WT | 0.28 ± 0.27 | 98 ± 0.18 | −1.43 ± 0.02 | 0.15 ± 0.001 |
| / |
| EiGS1-1-R59 | −1.5 ± 0.29 | 98 ± 0.16 | −1.39 ± 0.02 | 0.35 ± 0.003 |
| 2.3 | |
| Leaf extract of | EiGS-S | 0.007 ± 1.97 | 99 ± 2.25 | −1.21 ± 0.12 | 0.059 ± 0.005 |
| / |
| EiGS-R | 0.17 ± 2.7 | 100 ± 2.34 | −1.05 0.11 | 0.09 ± 0.009 |
| 1.5 |
The I50 values estimated for WT and R59 lines, and S and R populations are significantly different according to the t-test, P<0.0001.
Fig. 7.Enzymatic reaction kinetics of purified yeast recombinant EiGS1-1-WT and EiGS1-1-R59 proteins for the substrate glutamate and ATP. Data are means ±SE of three technical replicates of each sample.
Kinetic parameters of the purified yeast recombinant wild-type (WT) and mutant (R59) EiGS1-1 proteins
| GS variants | Substrate | Kinetic parameters |
| |
|---|---|---|---|---|
|
|
| |||
| EiGS1-1-WT | Glutamate | 6.9 ± 0.08 b | 0.27 ± 0.004 b | 0.035 |
| EiGS1-1-R59 | 14.7 ± 0.09 a | 0.52 ± 0.001 a | 0.035 | |
| EiGS1-1-WT | ATP | 17.4 ± 0.74 b | 0.45 ± 0.007 b | 0.026 |
| EiGS1-1-R59 | 21.3 ± 0.27 a | 0.75 ± 0.006 a | 0.035 | |
Data are means ±SE of three technical replicates of each sample, and the assay was repeated with similar results. Different letters in a column between WT and R59 genotypes indicate significant differences according to the t-test, P<0.01.